CORRESPONDENCE

Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story

  • Guven, Deniz Can MD
  • Deniz Can Guven, MD, Medical Oncology Clinic, Health Sciences University, Elazig City Hospital, Elazig, Turkey
Corresponding author: Deniz Can Guven, MD; e-mail: [email protected].
Journal of Clinical Oncology 43(5):p 616-616, February 10, 2025. | DOI: 10.1200/JCO-24-01878

Corresponding Article

Reply to: Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story

  • Verheijden, Rik J. MSc
  • de Groot, Jolien S. MD, PhD
  • Fabriek, Babs O. PhD
  • Hew, Miki N. MD, PhD
  • May, Anne M. PhD
  • Suijkerbuijk, Karijn P.M. MD, PhD,
Journal of Clinical Oncology 43(5):p 616-619, February 10, 2025. | DOI: 10.1200/JCO-24-02234
Copyright © 2024 by American Society of Clinical Oncology